Local consolidative therapy for the primary tumor in EGFR-mutant advanced non-small cell lung cancer following osimertinib plus chemotherapy: a protocol for a single-arm, open-label, phase 2 trial

Authors

Institutions

Publication Details

Journal
Translational Lung Cancer Research
Published
2025-10-01
DOI
https://doi.org/10.21037/tlcr-2025-922
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Local consolidative therapy for the primary tumor in EGFR-mutant advanced non-small cell lung cancer following osimertinib plus chemotherapy: a protocol for a single-arm, open-label, phase 2 trial

Jung Seop Eom, Hayoung Seong, Mi‐Hyun Kim, Soo Han Kim
Translational Lung Cancer Research
Lung Cancer Treatments and Mutations
article

Local consolidative therapy for the primary tumor in EGFR-mutant advanced non-small cell lung cancer following osimertinib plus chemotherapy: a protocol for a single-arm, open-label, phase 2 trial

Jung Seop Eom, Hayoung Seong, Mi‐Hyun Kim, Soo Han Kim
article en

Abstract

No abstract available for this paper.
Translational Lung Cancer ResearchVol. 14(10)
Pusan National University Hospital (KR), Pusan National University (KR)
Openalex Percentile: Top 55%
Lung Cancer Treatments and Mutations
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.